0001437749-23-026068.txt : 20230915
0001437749-23-026068.hdr.sgml : 20230915
20230915184951
ACCESSION NUMBER: 0001437749-23-026068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230915
DATE AS OF CHANGE: 20230915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blackburn Kelly
CENTRAL INDEX KEY: 0001640575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 231259808
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CervoMed Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA
STREET 2: SUITE 424
CITY: BOSTON
STATE: MA
ZIP: 02216
BUSINESS PHONE: (617) 744-4400
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA
STREET 2: SUITE 424
CITY: BOSTON
STATE: MA
ZIP: 02216
FORMER COMPANY:
FORMER CONFORMED NAME: Diffusion Pharmaceuticals Inc.
DATE OF NAME CHANGE: 20160115
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-09-15
0001053691
CervoMed Inc.
CRVO
0001640575
Blackburn Kelly
20 PARK PLAZA, SUITE 424
BOSTON
MA
02116
1
VP, Clinical Development
0
Stock Option (Right to Buy)
5.33
2023-09-15
4
A
0
16000
0
A
2033-09-15
Common Stock
16000
16000
D
The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023.
/s/ William R. Elder, attorney-in-fact for the Reporting Person
2023-09-15